今天A股科创板有新股申购！ 格隆汇获悉，6月27日，北京屹唐半导体科技股份有限公司（简称"屹唐半导体"或"屹唐股份"）申购，发行价格8.45元/ 股，保荐人为国泰海通证券股份有限公司。 鉴于今年A股打新赚钱效应较好，建议积极参与申购。据统计，截至6月26日，2025年登陆A股的51家新股上市首日全 部收涨，且首日平均涨幅超229%。可见打中大A新股后在上市首日卖出，赚钱的概率很大，只是打新中签率很低。 屹唐股份（688729）主要从事集成电路制造过程中所需晶圆加工设备的研发、生产和销售，面向全球集成电路制造厂 商提供包括干法去胶设备、快速热处理设备、干法刻蚀设备在内的集成电路制造设备及配套工艺解决方案。 根据Gartner统计数据，在快速热处理设备领域，2023年公司凭借13.05%的市场占有率位居全球第二，而排名第一的应 用材料市场占有率高达69.66%；在干法刻蚀领域，公司凭借0.21%的市场占有率位居全球第九，而前三大厂商泛林半 导体、东京电子及应用材料合计占有全球83.95%的市场份额。公司在快速热处理及干法刻蚀领域，与国际巨头相比市 场占有率仍有较大差距。 | 项目 | 2024 年度 | | 20 ...

Windtree rapidly advancing lower cost PHEXXI manufacturing under March 2025 sourcing agreement Contract inked with outside U.S manufacturer to cut PHEXXI manufacturing costs by over 50% by end of 2026 Tech transfer underway with validation batch manufacturing expected to begin in 2026 Evofem and Windtree exploring other partnerships WARRINGTON, Pa., June 26, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (Nasdaq: WINT) today announced that it has contracted with a pharma ...

Collaboration with French MedTech company, TISSIUM, has resulted in FDA approval for unique 3D-printed polymeric solution for repair of peripheral nerve damage3D Systems’ bioprinting system enabled production of a 3D-printed bioabsorbable medical device leveraging TISSIUM’s proprietary biomorphic programable polymers—a major industry milestone that sets new standard for high resolution elastomeric 3D-printed medical implantsBuilds on 3D Systems’ pioneering work to develop additive manufacturing solutions fo ...

exclusive new data providing key insights into the state of China's economy. Joining us now, China Beige Book CEO Leland Miller. Let's just run down the uh the list of things that that where you're seeing clear evidence of of maybe some slowdowns.Uh Leland, how how many things can you point to would you say right now. Are there a half dozen. I mean, at least the whole month looked poor.Uh and this is this is a bit surprising because the May data, our May data, official May data looked very good and of cours ...

Core Insights - Tornado Infrastructure Equipment Ltd. has entered into a private label manufacturing agreement with Ascend Hydrovacs Inc. to produce hydrovac units, which is expected to generate significant revenue for the company [1][3]. Group 1: Supply Agreement Details - CustomVac will manufacture 13-yard tipping tank hydrovac units exclusively for Ascend, tailored to meet specific operational requirements [2]. - The Supply Agreement includes a commitment for the delivery of proprietary hydrovac trucks over the next four fiscal years starting in 2026, estimated to generate minimum gross revenue of CAD$88.2 million [3][13]. - Ascend will pay Tornado an intellectual property fee of up to CAD$1.8 million per unit for rights to the co-developed hydrovac product design [3][13]. Group 2: Operational Developments - The partnership enhances CustomVac's position as a leading original equipment manufacturer in private label hydrovac manufacturing [4][13]. - Production will take place at CustomVac's advanced facility in Nisku, Alberta, with initial deliveries expected later this year [4][13]. - Tornado's new manufacturing facility in Red Deer is nearing completion, which is anticipated to improve operational efficiencies and increase capacity starting in Q3 2025 [4][13]. Group 3: Company Background - CustomVac specializes in manufacturing and servicing mobile vacuum equipment for various sectors including oil and gas, utilities, and environmental services [5][6]. - Tornado has sold over 1,800 hydrovacs since 2008 and is recognized as a leader in the vacuum truck industry [7].

Group 1 - The core objective is to focus on the '1+2+4+N' target task system to promote high-quality development and efficient governance in Zhoukou, aiming to contribute significantly to the construction of a national regional central port city [1][2] - The city plans to accelerate the development of a strong advanced manufacturing industry by nurturing strategic emerging industries such as biodegradable materials, biomedicine, and intelligent components, while upgrading traditional industries like textiles and special steel [1] - Zhoukou aims to enhance the digital transformation of enterprises, focusing on increasing the intelligence, sustainability, and profitability of the manufacturing sector through a structured approach [1] Group 2 - The construction of a port-type national logistics hub is prioritized, with a focus on developing the Zhoukou Port small collection operation area and dedicated railway lines to enhance modern, professional, and intelligent inland shipping [2] - The city intends to promote cultural prosperity by leveraging its status as a national historical and cultural city, aiming to develop a cultural tourism industry as a pillar of the local economy [2]

Financial Performance & Growth - Protolabs achieved $504 million in revenue in 2023[6] - The company's Non-GAAP gross margin was 45% in 2023[6] - Adjusted EBITDA reached $83 million in 2023[6] - Protolabs Network revenue experienced a 69% year-over-year growth in constant currencies in 2023[60] - The company's revenue increased by 5% year-over-year, excluding Japan, in 2023[56] Customer Base & Manufacturing - Protolabs has served over 53,000 customer contacts[6,36] - The company has manufactured over 450 million parts to date[6] - Over 85% of Fortune 500 companies in target industries are served by Protolabs[36] - More than 90% of revenue comes from returning customers[44] Market & Outlook - Protolabs operates in a $100 billion+ market[8,14,18] - The company anticipates Q1 2024 revenue between $120 million and $128 million, representing a growth range of -5% to 2% year-over-year[73] - Non-GAAP EPS for Q1 2024 is projected to be between $0.26 and $0.34, indicating a year-over-year growth range of -12% to 15%[73]

We hosted WuXi XDC's Head of IR & PR with investors on Jun 24 at our China Healthcare Corporate Day 2025. Bottom line: mgmt reiterated 1) high visibility of FY25 revenue growth guidance of over 35% y/y, backed with strong client demand in ADC development, particularly from emerging China Biotech companies; 2) technological leadership in ADC and bio-conjugates, e.g. diversified technology platform for DAR, payload, linker, etc., and the advantage of new molecule development; 3) on-track capacity expansion wi ...

Investigators criticized both Boeing and the Federal Aviation Administration as they released a summary of the report into Alaska Airlines Flight 1282. "The safety deficiencies that led to this accident should have been evident to Boeing and to the FAA," Jennifer Homendy, chair of the National Transportation Safety Board, said Tuesday."A long chain of events" led to a door plug coming off the Alaska Airlines 737 Max last January, she added. The plane, which left Boeing's factory 66 days earlier, was force ...

Transactions permanently retire approximately $88 million of debt, 41% of prior balance, at a meaningful discount to parRefinancing extends maturity with issuance of $92 million Convertible Senior Secured Notes due 2030Repurchase of 8 million shares, representing approximately 6% of the Company’s outstanding common stock, in connection with the transaction reduces dilution for equity holdersStrong remaining cash reserves support completion of restructuring efforts while maintaining continuity in key growth ...